SEC sues investors for insider trading in acquisition of biosciences corporation

[JURIST] The Securities and Exchange Commission (SEC) [official website] has filed an insider trading complaint [SEC release] against unknown investors in Martek Biosciences Corp. [corporate website], claiming that the investors purchased an unusually large number of call options in Martek in the two weeks preceding the December 21 announcement [DSM release] that DSM [corporate website] planned to purchase Martek. The SEC’s complaint, filed last week in the US District Court for the Southern District of New York [official website], alleges…

By | 2011-01-01T14:46:19+00:00 January 1st, 2011|Uncategorized|0 Comments

Leave A Comment

google-site-verification: googlede575d7e284d2c39.html